Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.
Abstract
The molecular mechanisms that underlie tumour progression are still poorly understood, but recently our knowledge of particular aspects of some of these processes has increased. Specifically, the identification of Snail, ZEB and some basic helix-loop-helix (bHLH) factors as inducers of epithelial-mesenchymal transition (EMT) and potent repressors of E-cadherin expression has opened new avenues of research with potential clinical implications.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides SNAIL-1, TGF-β, via a SMAD-dependent pathway, mediates the activation of Twist and ZEB-1 factors, which in turn can downregulate E-cadherin expression [27].”
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
RetractedEpithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,958
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Cano, A., Pérez-Moreno, M. A., Rodrigo, I., Locascio, A., Blanco, M. J., del Barrio, M. G., Portillo, F., & Nieto, M. A. (2000) · Nature Cell Biology · doi:10.1038/35000025 · Cited by 3,668
Tumour-cell invasion and migration: diversity and escape mechanisms
Friedl, P., & Wolf, K. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1075 · Cited by 3,222
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Molecular requirements for epithelial–mesenchymal transition during tumor progression
Huber, M. A., Kraut, N., & Beug, H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.001 · Cited by 1,821
Helix-Loop-Helix Proteins: Regulators of Transcription in Eucaryotic Organisms
Massari, M. E., & Murre, C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.429-440.2000 · Cited by 1,816
Cited by
Items 701–800 of 1,011
Foubert, E., Craene, B. D., & Berx, G. (2010) · Breast Cancer Research · doi:10.1186/bcr2585 · Cited by 102
Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges
Wu, B., Sodji, Q. H., & Oyelere, A. K. (2022) · Cancers · doi:10.3390/cancers14030552 · Cited by 99
“The TGF-β activation and overregulation could also induce EMT through the transcriptional regulation and expression of Snail families, ZEB families and bHLH families [112], which could induce malignant tumor growth [42,113].”
BackgroundZhao, F. H., Wang, M., Li, S., Bai, X., Bi, H.-L., Liu, Y., Ao, X., Jia, Z., & Wu, H. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.3 · Cited by 91
Ellis-Connell, A. L., Iempridee, T., Xu, M., & Mertz, J. E. (2010) · Journal of Virology · doi:10.1128/jvi.00923-10 · Cited by 94
Slorach, E. M., Chou, J., & Werb, Z. (2011) · Genes & Development · doi:10.1101/gad.1998111 · Cited by 96
McCrea, P. D., Gu, D., & Balda, B. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a002923 · Cited by 89
Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis
Lin, C.-W., Wang, L.-K., Wang, S.-P., Chang, Y.-L., Wu, Y.-Y., Chen, H.-Y., Hsiao, T.-H., Lai, W.-Y., Lu, H.-H., Chang, Y.-H., et al. (2016) · Nature Communications · doi:10.1038/ncomms13867 · Cited by 86
“Downregulation of epithelial cadherin (E-cadherin) and tight junction molecules, such as occludins and the zona occludens proteins, ZO-1/2, during solid tumour dissemination is recognized as a pivotal phenomenon that is tightly linked to cancer aggressiveness and patients’ outcomes 11–13 .”
Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC)
Hashiguchi, M., Ueno, S., Sakoda, M., Iino, S., Hiwatashi, K., Minami, K., Ando, K., Mataki, Y., Maemura, K., Shinchi, H., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-572 · Cited by 86
“Aberrant expression of ZEB1 in endometrial cancers, colorectal carcinomas and prostate cancer has been associated with aggressive disease, poor differentiation, the development of metastases and poor clinical prognosis [6,8-10].”
Sui, H., Zhu, L., Deng, W., & Li, Q. (2014) · Oncology Research and Treatment · doi:10.1159/000367802 · Cited by 86
van Nes, J. G. H., de Kruijf, E. M., Putter, H., Faratian, D., Munro, A. F., Campbell, F., Smit, V. T. H. B. M., Liefers, G., Kuppen, P. J. K., van de Velde, C. J. �., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1684-y · Cited by 88
Wang, Z., Ao, X., Shen, Z., Ao, L., Wu, X., Pu, C., Guo, W., Xing, W., He, M. Y., Yuan, H., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.61350 · Cited by 101
“Previous studies confirmed that many other transcription factors, including ZEB1, Twist and Slug, regulate EMT during cancer progression[72, 73].”
Lee, H. J., Park, M. K., Lee, E. J., & Lee, C. H. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.09.018 · Cited by 92
Dhillon, A. S., & Tulchinsky, E. M. (2014) · Oncogene · doi:10.1038/onc.2014.374 · Cited by 87
Ghosh, B., Benyumov, A. O., Ghosh, P., Jia, Y., Avdulov, S., Dahlberg, P. S., Peterson, M., Smith, K., Polunovsky, V. A., Bitterman, P. B., et al. (2009) · ACS Chemical Biology · doi:10.1021/cb9000475 · Cited by 85
Matsuno, Y., Coelho, A. L., Járai, G., Westwick, J. K., & Hogaboam, C. M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.01.021 · Cited by 97
Qian, P., Banerjee, A., Wu, Z.-S., Zhang, X., Wang, H., Pandey, V., Zhang, W.-J., Lv, X.-F., Tan, S., Lobie, P. E., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1507 · Cited by 86
Kan, J., Yen, M., Wang, J., Wu, D., Chiu, Y., Ho, Y., & Kuo, P. (2016) · Oncotarget · doi:10.18632/oncotarget.9140 · Cited by 85
MOF Acetylates the Histone Demethylase LSD1 to Suppress Epithelial-to-Mesenchymal Transition
Luo, H., Shenoy, A. K., Li, X., Jin, Y., Jin, L., Cai, Q., Tang, M., Liu, Y., Chen, H., Reisman, D., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.050 · Cited by 85
Factors Regulating or Regulated by Myogenic Regulatory Factors in Skeletal Muscle Stem Cells
Shirakawa, T., Toyono, T., Inoue, A., Matsubara, T., Kawamoto, T., & Kokabu, S. (2022) · Cells · doi:10.3390/cells11091493 · Cited by 102
Laffin, B., Wellberg, E. A., Kwak, H., Burghardt, R. C., Metz, R. P., Gustafson, T. L., Schedin, P. S., & Porter, W. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01701-07 · Cited by 85
Snail-induced EMT promotes cancer stem cell-like properties in head and neck cancer cells
Ota, I., Masui, T., Kurihara, M., Yook, J. I., Mikami, S., Kimura, T., Shimada, K., Konishi, N., Yane, K., Yamanaka, T., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.4348 · Cited by 85
Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch
Lee, S. Y., Jeon, H. M., Ju, M. K., Jeong, E. K., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2016) · Oncotarget · doi:10.18632/oncotarget.6879 · Cited by 85
Chen, J., Yuan, W., Wu, L., Tang, Q., Xia, Q., Ji, J., Liu, Z., Ma, Z., Zhou, Z., Cheng, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.14283 · Cited by 86
“Moreover, Notch1 promotes EMT by regulating EMT-transcription factors such as Twist1 in CRC [13].”
BackgroundUCH-L1 promotes cancer metastasis in prostate cancer cells through EMT induction
Jang, M. J., Baek, S. H., & Kim, J. H. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.01.006 · Cited by 84
Kim, W. K., Byun, W. S., Chung, H., Oh, J., Park, H. J., Choi, J. S., & Lee, S. K. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.009 · Cited by 88
Annexin A1 attenuates EMT and metastatic potential in breast cancer
Macho‐Maschler, S., Gebeshuber, C. A., Wiedemann, E., Alacakaptan, M., Schreiber, M. J., Custic, I., & Beug, H. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000095 · Cited by 83
Fan, X., Wan, X., Yang, Z.-L., Fu, X.-H., Huang, Y. J., Chen, D.-K., Song, S.-X., Liu, Q., Xiao, H.-Y., Wang, L., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.03.029 · Cited by 84
“The important role of EMT may be attributable to its aberrant regulation by transcriptional factors, including Snail (SNAI1 and SNAI2), ZEB (ZEB1 and ZEB2), and basic helix-loop-helix families (E47 and TWIST) [14].”
BackgroundSNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin
Deep, G., Jain, A. K., Ramteke, A. S., Ting, H., Vijendra, K. C., Gangar, S. C., Agarwal, C., & Agarwal, R. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-37 · Cited by 89
“Importantly, the loss of E-cadherin function has been implicated in the progression and metastasis of several malignancies including PCA [18,19].”
BackgroundEMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours
Bornachea, O., Santos, M., Martínez‐Cruz, A. B., García‐Escudero, R., Dueñas, M., Costa, C., Segrelles, C., Lorz, C., Buitrago, A., Sáiz-Ladera, C., et al. (2012) · Scientific Reports · doi:10.1038/srep00434 · Cited by 94
Liu, W., Wang, S., Sun, Q., Yang, Z. H., Liu, M., & Tang, H. (2017) · International Journal of Cancer · doi:10.1002/ijc.31232 · Cited by 88
“Epithelial-mesenchymal transition (EMT) has been considered to be a key program associated with the invasion and metastasis of several malignant tumors, including CRC.4,5 EMT allows the epithelial cells to disrupt cell–cell adherence, lose their apical-basal polarity and acquire mesenchymal characteristics through cyt…”
BackgroundRetractedMolecular mechanism involved in epithelial to mesenchymal transition
Jayachandran, J., Srinivasan, H., & Mani, K. P. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108984 · Cited by 97
Macrophages in tumor: An inflammatory perspective
Goswami, K. K., Bose, A., & Baral, R. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108875 · Cited by 94
Chen, X.-H., Liu, Z., Zhang, G., Wei, W., Wang, X., Wang, H., Ke, H., Zhang, F., Wang, H.-S., Cai, S., et al. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.12.017 · Cited by 86
Teng, Y., Mei, Y., Hawthorn, L., & Cowell, J. K. (2013) · Oncogene · doi:10.1038/onc.2012.565 · Cited by 87
“Loss of E-cadherin at the cell membrane, for example, is frequently associated with progression to invasion (39,40).”
BackgroundHan, W., Zhu, Q., Hu, J., Li, P., Zhang, F., & Li, N. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.02.029 · Cited by 83
Hugo, H. J., Kokkinos, M. I., Blick, T., Ackland, M. L., Thompson, E. W., & Newgreen, D. F. (2011) · Cells Tissues Organs · doi:10.1159/000320174 · Cited by 83
PROP1 triggers epithelial-mesenchymal transition-like process in pituitary stem cells
Millan, M. I. P., Brinkmeier, M. L., Mortensen, A. H., & Camper, S. A. (2016) · eLife · doi:10.7554/elife.14470 · Cited by 85
“…from Prop1 mutant mice, and reduction in Zeb2 expression is sufficient to mimic some of the properties of Prop1-deficient CFCs. ZEB family proteins reduce epithelial marker expression and increase mesenchymal marker expression during the induction of EMT in other organs (Peinado et al., 2007).”
BackgroundMyosin II promotes the anisotropic loss of the apical domain during Drosophila neuroblast ingression
Simões, S. D. M., Oh, R. Y., Wang, M. F. Z., Fernández‐González, R., & Tepaß, U. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201608038 · Cited by 96
“The expression of the Snail family of transcriptional repressors has been directly associated with EMT initiation (Peinado et al., 2007).”
BackgroundA miRNA signature associated with human metastatic medullary thyroid carcinoma
Santarpia, L., Călin, G. A., Adam, L., Ye, L., Fusco, A., Giunti, S., Christina Thaller, B., Paladini, L., Zhang, X., Jiménez, C., et al. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0357 · Cited by 89
Markopoulos, G. S., Roupakia, E., Marcu, K. B., & Kolettas, E. (2019) · Cells · doi:10.3390/cells8101143 · Cited by 81
Exploring the Crosstalk between Inflammation and Epithelial‐Mesenchymal Transition in Cancer
Chattopadhyay, I., Ambati, R. R., & Gundamaraju, R. (2021) · Mediators of Inflammation · doi:10.1155/2021/9918379 · Cited by 90
Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice
Tanaka, K., Tanaka, Y., Namba, T., Azuma, A., & Mizushima, T. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.025 · Cited by 89
Tumour-microenvironmental interactions: paths to progression and targets for treatment
Box, C., Rogers, S. J., Mendiola, M., & Eccles, S. A. (2010) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2010.06.004 · Cited by 91
Chandrakesan, P., Roy, B. C., Jakkula, L. U. M. R., Ahmed, I., Ramamoorthy, P., Tawfik, O. W., Papineni, R. V. L., Houchen, C. W., Anant, S., & Umar, S. (2013) · Oncogene · doi:10.1038/onc.2013.210 · Cited by 85
Li, H., Xu, F., Li, S., Zhong, A., Meng, X., & Lai, M. (2016) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1129481 · Cited by 94
Zhu, R., Liu, Y., Zhou, H., Li, L., Li, Y., Ding, F., Cao, X., & Liu, Z. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.025 · Cited by 89
Chang, A. T., Liu, Y., Ayyanathan, K., Benner, C. W., Jiang, Y., Prokop, J. W., Paz, H., Wang, D., Li, H., Fu, X., et al. (2015) · Genes & Development · doi:10.1101/gad.242842.114 · Cited by 82
“This developmental transcription factor also plays a critical role in tumor progression, and its expression is associated with poor prognosis and distant metastasis in many human solid tumors (Peinado et al. 2007; Eckert et al. 2011; Tsai et al. 2012).”
BackgroundQu, Y., Li, W., Hellem, M. R., Rostad, K., Popa, M. L., McCormack, E., Oyan, A. M., Kalland, K., & Ke, X. (2013) · International Journal of Cancer · doi:10.1002/ijc.28056 · Cited by 91
miR-675 Mediates Downregulation of Twist1 and Rb in AFP-Secreting Hepatocellular Carcinoma
Hernandez, J. M., Elahi, A. H., Clark, C. W., Wang, J., Humphries, L. A., Centeno, B., Bloom, G. C., Fuchs, B. C., Yeatman, T. J., & Shibata, D. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3106-3 · Cited by 85
PBX3 Is Part of an EMT Regulatory Network and Indicates Poor Outcome in Colorectal Cancer
Lamprecht, S., Kaller, M., Schmidt, E. M., Blaj, C., Schiergens, T. S., Engel, J., Jung, A., Hermeking, H., Grünewald, T. G. P., Kirchner, T., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2572 · Cited by 86
“PBX3 is required for EMT in colon cancer cells EMT can be induced in colon cancer cells by ectopic expression of SNAIL or ZEB1 (37, 38), and we applied this approach to test whether PBX3 expression is EMT dependent.”
Detachment of captured cancer cells under flow acceleration in a bio-functionalized microchannel
Cheung, L. S. L., Zheng, X., Stopa, A., Baygents, J. C., Guzman, R. Z., Schroeder, J. A., Heimark, R. L., & Zohar, Y. (2009) · Lab on a Chip · doi:10.1039/b822172c · Cited by 85
Katoh (2009) · International Journal of Oncology · doi:10.3892/ijo_00000328 · Cited by 81
Pathophysiological Consequences of HIF Activation: HIF as a Modulator of Fibrosis
Haase, V. H. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05030.x · Cited by 92
He (2010) · Oncology Reports · doi:10.3892/or_00000794 · Cited by 81
Funasaka, T., Hogan, V., & Raz, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0488 · Cited by 81
Tsai, Y., & Wu, K. (2013) · International Journal of Cancer · doi:10.1002/ijc.28190 · Cited by 87
“One important aspect is that HIF-1a activates genes encoding glucose transporters (e.g., Glut-1) and glycolytic enzymes, which take up glucose and convert it to lactate.21 The other two critical molecules that are activated by HIF-1a are PDK1 that shunts pyruvate away from mitochondria, and Bcl2/adenovirus E1B 19 kDa…”
BackgroundGuo, F., Cogdell, D. E., Hu, L., Yang, D., Sood, A. K., Xue, F., & Zhang, W. (2014) · Oncology Reports · doi:10.3892/or.2014.3106 · Cited by 84
“ZEB1 and ZEB2, members of the ZEB family, have been shown to induce EMT through repression of E-cadherin and to promote tumor progression and metastatic spread (31-33).”
BackgroundGenomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
Tao, C., Huang, K., Shi, J., Hu, Q., Li, K., & Zhu, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00183 · Cited by 98
The role of epithelial-mesenchymal transition in regulating radioresistance
Zhou, S., Zhang, M., Chao Hui, Z. H. O. U., Wang, W., Yang, H., & Ye, W. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102961 · Cited by 81
TGFβ signaling networks in ovarian cancer progression and plasticity
Kumari, A., Shonibare, Z., Monavarian, M., Arend, R. C., Lee, N. Y., Inman, G. J., & Mythreye, K. (2021) · Clinical & Experimental Metastasis · doi:10.1007/s10585-021-10077-z · Cited by 81
Meng, F., Wei, J.-C., Qu, K., Wang, Z.-X., Wu, Q.-F., Tai, M.-H., Liu, H.-C., Zhang, R.-Y., & Liu, C. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i1.196 · Cited by 85
Fan, H., Zhao, X., Sun, S., Luo, M., & Guan, J.-L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.420497 · Cited by 79
Lenferink, A. E. G., Cantin, C., Nantel, A., Wang, E., Durocher, Y., Banville, M., Paul-Roc, B., Marcil, A., Wilson, M. R., & O'Connor-McCourt, M. D. (2010) · Oncogene · doi:10.1038/onc.2009.399 · Cited by 81
“Clusterin has been shown to bind to a wide range of soluble ligands (Wilson and Easterbrook-Smith, 2000; Ammar and Closset, 2008; Jo et al., 2008), which likely results from clusterin’s ability to chaperone stressed proteins (Humphreys et al., 1999; Poon et al., 2002).”
BackgroundRachagani, S., Macha, M. A., Ponnusamy, M. P., Haridas, D., Kaur, S., Jain, M., & Batra, S. K. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs225 · Cited by 85
ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR
Thomas, C. G., Rajapaksa, G. K., Nikolos, F., Hao, R., Katchy, A., McCollum, C. W., Bondesson, M., Quinlan, P., Thompson, A. M., Krishnamurthy, S., et al. (2012) · Breast Cancer Research · doi:10.1186/bcr3358 · Cited by 87
Kim, Y.-S., Hwang, K., Hyun, S., Nam, K., Lee, C., & Choi, K. (2015) · Chemical Research in Toxicology · doi:10.1021/tx500443p · Cited by 86
Kumar, D., Kumar, S., Gorain, M., Tomar, D., Patil, H. S., Radharani, N. N. V., Kumar, T. V. S., Patil, T. V., Thulasiram, H. V., & Kundu, G. C. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.07.024 · Cited by 81
“During cancer progression, the epithelial-to-mesenchymal transition (EMT) contributes to accelerating tumor growth and metastasis through activation of Snail, Slug, and Zeb (Mani et al., 2008; Peinado et al., 2007).”
BackgroundHuman trophoblast epithelial-mesenchymal transition in abnormally invasive placenta†
DaSilva‐Arnold, S. C., Zamudio, S., Al‐Khan, A., Alvarez‐Perez, J. R., Mannion, C. M., Koenig, C., Luke, D., Perez, A. M., Petroff, M. G., Alvarez, M., et al. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy042 · Cited by 85
“The latter, identified as an EMT “master regulator” [35, 36], is almost 200-fold higher in first trimester EVT compared to CTB and hence is a primary candidate for mediation of the differentiation-associated EMT process in early pregnancy.”
BackgroundLiu, C.-W., Li, C.-H., Peng, Y., Cheng, Y., Chen, H., Liao, P.-L., Kang, J., & Yeng, M.-H. (2014) · Oncotarget · doi:10.18632/oncotarget.2006 · Cited by 79
“Recent studies have indicated that the Snail protein is sometimes associated with invasion, metastasis, and/or poor prognosis [6].”
Haddad, Y., Choi, W., & McConkey, D. J. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1733 · Cited by 86
Blaj, C., Schmidt, E. M., Lamprecht, S., Hermeking, H., Jung, A., Kirchner, T., & Horst, D. A. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2821 · Cited by 89
Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer
Legras, A., Pécuchet, N., Imbeaud, S., Pallier, K., Didelot, A., Roussel, H., Gibault, L., Fabre, E., Pimpec‐Barthes, F. L., Laurent‐Puig, P., et al. (2017) · Cancers · doi:10.3390/cancers9080101 · Cited by 88
“induced to maintain the migratory mesenchymal state [33] suggesting an orchestration in time of the process.”
BackgroundCao, Y. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0188-9 · Cited by 94
Gödde, N., Galea, R. C., Elsum, I. A., & Humbert, P. O. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9180-2 · Cited by 96
The microRNA-200 Family Regulates Epithelial to Mesenchymal Transition
Paterson, E. L., Kolesnikoff, N., Gregory, P. A., Bert, A. G., Khew‐Goodall, Y., & Goodall, G. J. (2008) · The Scientific World JOURNAL · doi:10.1100/tsw.2008.115 · Cited by 87
Reprogramming during epithelial to mesenchymal transition under the control of TGFβ
Tan, E., Olsson, A.-K., & Moustakas, A. (2014) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.983794 · Cited by 92
“Epigenetic modifications may not be determined by specific DNA sequences, but DNA and histone modifying factors often interact and are recruited to the chromatin by, for example, EMT-TFs which recognize E-box DNA elements with the consensus 5’-CANNTG-3’, and therefore exhibit gene or sequence specific functional effec…”
BackgroundInfluentialYamakoshi, S., Bai, R., Chaen, T., Ideta, A., Aoyagi, Y., Sakurai, T., Konno, T., & Imakawa, K. (2011) · Reproduction · doi:10.1530/rep-11-0364 · Cited by 79
LARP7 suppresses P-TEFb activity to inhibit breast cancer progression and metastasis
Ji, X., Lu, H., Zhou, Q., & Luo, K. (2014) · eLife · doi:10.7554/elife.02907 · Cited by 85
“Shortly after initiation of transcription, Pol II pauses near the transcription start site largely due to the actions of two negative transcription elongation factors NELF and DSIF (Peterlin and Price, 2006).”
BackgroundNatsuizaka, M., Ohashi, S., Wong, G. S., Ahmadi, A., Kalman, R. A., Budo, D., Klein–Szanto, A. J., Herlyn, M., Diehl, J. A., & Nakagawa, H. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq108 · Cited by 79
Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells
Shenoy, A. K., Jin, Y., Luo, H., Tang, M., Pampo, C., Shao, R., Siemann, D. W., Wu, L., Heldermon, C. D., Law, B. K., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86623 · Cited by 86
“The zinc finger transcription factor Snail is a central inducer of EMT (19, 20).”
BackgroundDong, D. F., Cai, G., Ning, Y., Wang, J., Lv, Y., Hong, Q., Cui, S., Fu, B., Guo, Y.-N., & Chen, X. (2017) · Oncotarget · doi:10.18632/oncotarget.14884 · Cited by 83
“Renal expression of α-smooth muscle actin (α-SMA), a specific marker of mesenchymal fibroblasts, and the transcription factor Zeb1, an inducer of EMT [16] were higher in the OAL group than in the YAL group.”
BackgroundZheng, J., Li, C., Wu, X., Liu, M., Sun, X., Yang, Y., Hao, M., Sheng, S., Sun, Y., Zhang, H., et al. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.11.034 · Cited by 78
Romero‐Pérez, L., López-García, M. Á., Díaz‐Martín, J., Biscuola, M., Castilla, M. Á., Tafe, L. J., Garg, K., Oliva, E., Matías‐Guiu, X., Soslow, R. A., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.93 · Cited by 79
Li, Q., Sodroski, C. N., Lowey, B., Schweitzer, C. J., Cha, H., Zhang, F., & Liang, T. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602701113 · Cited by 75
“Many other transcription factors such as Snail1, Slug, ZEB1, and Twist may also suppress E-cadherin directly or indirectly (36).”
BackgroundTsoumas, D., Nikou, S., Giannopoulou, E., Tsaniras, S. C., Sirinian, C., Maroulis, I. C., Taraviras, S. L., Zolota, V., Kalofonos, H. P., & Bravou, V. (2018) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20071 · Cited by 85
Jin, Y., Zhang, Y., Li, B., Zhang, J., Dong, Z., Hu, X., & Wan, Y. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.11.269 · Cited by 80
Epithelial Mesenchymal Transition in Human Ocular Chronic Graft-Versus-Host Disease
Ogawa, Y., Shimmura, S., Kawakita, T., Yoshida, S., Kawakami, Y., & Tsubota, K. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090318 · Cited by 84
Forsyth, C. B., Tang, Y., Shaikh, M. W., Zhang, L., & Keshavarzian, A. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01061.x · Cited by 77
Lei, W., Zhang, K., Pan, X., Hu, Y., Wang, D., Yuan, X., Shu, G., & Song, J. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.05.006 · Cited by 89
Wei, P., Chang, Y., Ho, Y., Lee, C., Yang, Y.-Y., An, J., & Lin, S.-Y. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181a6ce7e · Cited by 78
Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
Ronca, R., Salle, E. D., Giacomini, A., Leali, D., Alessi, P., Coltrini, D., Ravelli, C., Matarazzo, S., Ribatti, D., Vermi, W., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0487 · Cited by 78
“Several transcription factors repress E-cadherin expression, including Snai1, Snai2, ZEB1, ZEB2/ SIP1, Twist proteins, and E47 (42), leading to the induction of a mesenchymal phenotype.”
BackgroundAspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion
Cooke, N. M., Spillane, C. D., Sheils, O. M., O’Leary, J. J., & Kenny, D. J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1634-x · Cited by 88
WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer
Chiang, K.-C., Yeh, C.-N., Chung, L.-C., Feng, T.-H., Sun, C.-C., Chen, M.-F., Jan, Y.-Y., Yeh, T.-S., Chen, S.-C., & Juang, H.-H. (2015) · Scientific Reports · doi:10.1038/srep08686 · Cited by 77
Role of IQGAP3 in metastasis and epithelial–mesenchymal transition in human hepatocellular carcinoma
Shi, Y., Qin, N., Zhou, Q., Chen, Y., Huang, S., Chen, B., Shen, G., & Jia, H. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1275-8 · Cited by 76
Kang, E., Seo, J., Yoon, H., & Cho, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073591 · Cited by 90
“Snail binds to promoter regions of target genes with a higher affinity than Slug [93,94].”
BackgroundNairismägi, M., Vislovukh, A. A., Meng, Q., Kratassiouk, G., Beldiman, C., Petretich, M., Groisman, R., Füchtbauer, E.-M., Harel‐Bellan, A., & Groisman, I. (2012) · Oncogene · doi:10.1038/onc.2011.650 · Cited by 81
Deshière, A., Duchemin-Pelletier, E., Spreux, E., Ciais, D., Combes, F., Vandenbrouck, Y., Couté, Y., Mikaélian, I., Giusiano, S., Charpin, C., et al. (2012) · Oncogene · doi:10.1038/onc.2012.165 · Cited by 90
Systematic Interrogation of 3q26 Identifies TLOC1 and SKIL as Cancer Drivers
Hägerstrand, D., Tong, A., Schumacher, S. E., Ilić, N., Shen, R. R., Cheung, H. W., Vázquez, F., Shrestha, Y., Kim, S. Y., Giacomelli, A. O., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0592 · Cited by 88
Liu, Y., Xin, Y., Ye, F., Wang, W., Lu, Q., Kaplan, H. J., & Dean, D. C. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4321 · Cited by 77
Epithelial-mesenchymal transition in morphogenesis, cancer progression and angiogenesis
Ribatti, D. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.02.041 · Cited by 85
Metadata
- Authors
- Peinado, H., Olmeda, D., & Cano, A.
- Affiliations
- Consejo Superior de Investigaciones Científicas (ES)
- Corresponding author
- Cano, Amparo
- Venue
- Nature reviews. Cancer
- Published
- 2007-05-17
- Volume
- 7
- Issue
- 6
- Pages
- 415-428
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2025647419
- Cited by
- 3,121
- References
- 178
- Citations by year
- 2026: 38 · 2025: 64 · 2024: 75 · 2023: 108 · 2022: 107 · 2021: 158 · 2020: 165 · 2019: 181 · 2018: 205 · 2017: 218 · 2016: 237 · 2015: 201 · 2014: 226 · 2013: 225 · 2012: 237
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Funders
- Fundación Científica Asociación Española Contra el Cáncer
- Ministerio de Economía y Competitividad
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- snails, ZEB, bHLH transcription factors, epithelial-mesenchymal transition, E-cadherin repression, tumor progression, epithelial phenotype, metastasis
- MeSH terms
- Snail Family Transcription Factors, Zinc Finger E-box-Binding Homeobox 1, Cell Adhesion, Cell Movement, Epithelium, Humans, Models, Biological, Neoplasm Invasiveness, Neoplasms, Phenotype, Protein Processing, Post-Translational, Repressor Proteins, Transcription Factors, Signal Transduction, Cadherins, Homeodomain Proteins, Disease Progression, Helix-Turn-Helix Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.